Astragaloside IV alleviates lipopolysaccharide‐induced preeclampsia‐like phenotypes via suppressing the inflammatory responses

Astragaloside IV alleviates lipopolysaccharide‐induced preeclampsia‐like phenotypes via suppressing the inflammatory responses

Abstract Preeclampsia (PE) is a major cause of perinatal and maternal mortality and morbidity, which affects 2% to 8% of pregnancies in the world. The aberrant maternal inflammation and angiogenic imbalance have been demonstrated to contribute to the pathogenesis of PE. This research aimed to invest...

Full description

Bibliographic Details
Main Authors: Dilihuma Tuerxun, Remila Aierken, Yan‐Mei Zhang, Ying Huang, Shuang Sui, Xiao‐Ying Li, Zulifeiya Abulikemu, Nuerbiye Dilixiati
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Astragaloside IV
hypertension
inflammation
preeclampsia
Online Access:https://doi.org/10.1002/kjm2.12313

Internet

https://doi.org/10.1002/kjm2.12313

Similar Items